Sept 28 2019 Infection Control (Required) + Substance Abuse (Required for DEA License) + Risk Mgmt. 9 ceu
Infection Control (Required) + Substance Abuse (Required for DEA License) + Risk Mgmt.
8:00 am - 10:00 am Featured Course: Dental Law & Ethics:
"Title AB239 or the NV Legislature's attempt to fix the AB474 Controlled Substance Rx writing disaster"
Dr Dan Orr II, DDS, PhD, JD, MD, MS
Description: AB474 has been an unmitigated disaster that the NV Legislature continues to congratulate itself on. Sure, CS prescriptions are down 40%, but is that because doctors are now magically writing CS more judiciously or because AB474 imposes draconian regulatory, civil, and criminal penalties? Patients are not obtaining their CS from licensed doctors, where could their sources be now? Why is there a pet abuse epidemic documented over the past year? Why has the CDC issued a clarification to states whose new statutes have misused its opiate prescribing guidelines? And finally, why does AB239 propose even more penalty sources for doctors than ever before?
10:00 am - 12:00 pm
Substance Abuse- 2 ceu , Dr Don Havins MD, JD
Associate Dean, Professor and Director of Medical Jurisprudence, Professor of Ophthalmology Touro University Nevada
Course Description: Opioid Abuse Course Description: This two hour lecture presentation will provide the participant with evidence-based information regarding the science, and solution to the current problem concerning misuse of centrally acting opioid analgesics for acute dental pain. The use of alternative non-centrally acting obtundent medications will be described according to current guidelines established by the FDA, CDC and ADA
Opioid Abuse Course Description: This two hour lecture presentation will provide the participant with evidence-based information regarding the science, and solution to the current problem concerning misuse of centrally acting opioid analgesics for acute dental pain. The use of alternative non-centrally acting obtundent medications will be described according to current guidelines established by the FDA, CDC and ADA
Lunch & Learn 1 ceu "Documentation & Risk Management- Protecting your Assets" Dr. Benjamin Dyches DDS, JD
Course Description: Dentists provide care in high-risk environments that make them targets in our legal system. Legal entanglements in healthcare are all but inevitable. All too often we see good doctors whose careers and lives have been ruined without just cause. This course will take attendees through two crucial cases, illustrating principles of general liability, medical malpractice, and state board procedures. Attendees will learn about corporate and legal structures, where they may be personally vulnerable, which legal entities can protect personal and business assets, and how to build professional license safeguards into their legal structures. Attendees will also learn how legal structuring opens the door to valuable tax benefits.
1:00 pm - 4:00 pm Infection Prevention 4 ceu
Christine Haskin, MS, DDS, PhD
Dr. Haskin received a BA in Microbiology from University of Texas at Austin, a MS in Cell Biology and Biochemistry from Texas State University. Her dental degree is from UTHSC Dental School at San Antonio and her PhD in Cellular and Structural Biology is from UTHSC San Antonio Graduate School of Biomedical Sciences. She completed a GPR in Hospital Dentistry at the UTHSC and Medical Center Hospital. She is a Professor-in-Residence in Clinical Sciences at the UNLV School of Dental Medicine. She has been an infection control inspector for NSBDE since 2009. In addition to lecturing on infection control, she also lectures on the clinical impact of systemic disease on the delivery of dental care and dental pharmacotherapeutics.
Advanced Dental CE is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing education programs of this program provider are accepted by the AGD for Fellowship/Mastership and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends to 12/31/2019. Provider ID# 373308